Symbols / NKTX Stock $3.09 -6.93% Nkarta, Inc.
NKTX (Stock) Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Market Cap | 236.68M | Enterprise Value | — | Income | — | Sales | — | Book/sh | — | Cash/sh | — |
| Dividend Yield | — | Payout | — | Employees | — | IPO | — | P/E | — | Forward P/E | — |
| PEG | — | P/S | — | P/B | — | P/C | — | EV/EBITDA | — | EV/Sales | — |
| Quick Ratio | — | Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — | EPS (ttm) | — | EPS next Y | — |
| EPS Growth | — | Revenue Growth | — | Earnings | — | ROA | — | ROE | — | ROIC | — |
| Gross Margin | — | Oper. Margin | — | Profit Margin | — | Shs Outstand | — | Shs Float | — | Short Float | — |
| Short Ratio | — | Short Interest | — | 52W High | — | 52W Low | — | Beta | — | Avg Volume | — |
| Volume | — | Target Price | — | Recom | — | Prev Close | $3.32 | Price | $3.09 | Change | -6.93% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
- NKTX Stock Up on Upbeat Regulatory Update on Lead Autoimmune Program - Yahoo Finance Fri, 17 Apr 2026 14
- Nkarta (NKTX) Stock Dividend Safety (Underperforming) 2026-04-20 - MACD Signals - Cổng thông tin điện tử Tỉnh Sơn La Mon, 20 Apr 2026 15
- $NKTX stock is up 13% today. Here's what we see in our data. - Quiver Quantitative hu, 16 Apr 2026 19
- What date does Nkarta's (NKTX) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research Fri, 17 Apr 2026 07
- Nkarta (NKTX) Stock: Why It Could Change (In Focus) 2026-04-18 - Professional Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai Sat, 18 Apr 2026 22
- Nkarta targets 2-hour monitoring, not overnight stays, in cell therapy trials - Stock Titan Wed, 15 Apr 2026 20
- Nkarta wins FDA nod for new trial protocol (NKTX:NASDAQ) - Seeking Alpha hu, 16 Apr 2026 17
- Nkarta CEO Hastings sells $53,915 in NKTX stock - Investing.com ue, 20 Jan 2026 08
- Nkarta leaders to discuss autoimmune cell therapy at Needham event - Stock Titan hu, 09 Apr 2026 07
- [EFFECT] Nkarta, Inc. SEC Filing - Stock Titan Sun, 05 Apr 2026 07
- Insider Sale: Chief Executive Officer of $NKTX Sells 26,046 Shares - Quiver Quantitative ue, 20 Jan 2026 08
- Nkarta (NASDAQ: NKTX) launches $100M ATM shelf via Stifel as sales agent - Stock Titan Fri, 03 Apr 2026 07
- Is Nkarta (NKTX) Stock Good for Beginners | Price at $2.37, Up 2.16% - Profit Potential - Cổng thông tin điện tử Tỉnh Sơn La Mon, 06 Apr 2026 07
- Nkarta pushes autoimmune cell therapy to higher dose, cash lasts to 2029 - Stock Titan Wed, 25 Mar 2026 07
- Nkarta (NASDAQ: NKTX) launches $100M at-the-market stock sale plan - Stock Titan Wed, 25 Mar 2026 07
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
122.00
-4.83%
|
128.19
-2.63%
|
131.65
+10.67%
|
118.95
|
| Research And Development |
|
90.43
-6.53%
|
96.74
-0.03%
|
96.77
+6.46%
|
90.90
|
| Selling General And Administration |
|
31.57
+0.38%
|
31.45
-9.83%
|
34.88
+24.30%
|
28.06
|
| General And Administrative Expense |
|
31.57
+0.38%
|
31.45
-9.83%
|
34.88
+24.30%
|
28.06
|
| Other Gand A |
|
31.57
+0.38%
|
31.45
-9.83%
|
34.88
+24.30%
|
28.06
|
| Total Expenses |
|
122.00
-4.83%
|
128.19
-2.63%
|
131.65
+10.67%
|
118.95
|
| Operating Income |
|
-122.00
+4.83%
|
-128.19
+2.63%
|
-131.65
-10.67%
|
-118.95
|
| Total Operating Income As Reported |
|
-122.00
+4.83%
|
-128.19
+2.63%
|
-131.65
-10.67%
|
-118.95
|
| EBITDA |
|
-112.80
+5.24%
|
-119.04
+5.36%
|
-125.78
-8.14%
|
-116.32
|
| Normalized EBITDA |
|
-112.80
+5.24%
|
-119.04
+5.36%
|
-125.78
-8.14%
|
-116.32
|
| Reconciled Depreciation |
|
9.19
+0.45%
|
9.15
+55.94%
|
5.87
+122.56%
|
2.64
|
| EBIT |
|
-122.00
+4.83%
|
-128.19
+2.63%
|
-131.65
-10.67%
|
-118.95
|
| Net Income |
|
-104.08
+4.33%
|
-108.79
+7.41%
|
-117.50
-3.22%
|
-113.84
|
| Pretax Income |
|
-104.08
+4.33%
|
-108.79
+7.41%
|
-117.50
-3.22%
|
-113.84
|
| Net Non Operating Interest Income Expense |
|
15.49
-19.79%
|
19.32
+36.93%
|
14.11
+152.45%
|
5.59
|
| Net Interest Income |
|
15.49
-19.79%
|
19.32
+36.93%
|
14.11
+152.45%
|
5.59
|
| Interest Income Non Operating |
|
15.49
-19.79%
|
19.32
+36.93%
|
14.11
+152.45%
|
5.59
|
| Interest Income |
|
15.49
-19.79%
|
19.32
+36.93%
|
14.11
+152.45%
|
5.59
|
| Other Income Expense |
|
2.42
+2680.46%
|
0.09
+107.14%
|
0.04
+108.94%
|
-0.47
|
| Other Non Operating Income Expenses |
|
2.42
+2680.46%
|
0.09
+107.14%
|
0.04
+108.94%
|
-0.47
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-104.08
+4.33%
|
-108.79
+7.41%
|
-117.50
-3.22%
|
-113.84
|
| Net Income From Continuing Operation Net Minority Interest |
|
-104.08
+4.33%
|
-108.79
+7.41%
|
-117.50
-3.22%
|
-113.84
|
| Net Income From Continuing And Discontinued Operation |
|
-104.08
+4.33%
|
-108.79
+7.41%
|
-117.50
-3.22%
|
-113.84
|
| Net Income Continuous Operations |
|
-104.08
+4.33%
|
-108.79
+7.41%
|
-117.50
-3.22%
|
-113.84
|
| Normalized Income |
|
-104.08
+4.33%
|
-108.79
+7.41%
|
-117.50
-3.22%
|
-113.84
|
| Net Income Common Stockholders |
|
-104.08
+4.33%
|
-108.79
+7.41%
|
-117.50
-3.22%
|
-113.84
|
| Diluted EPS |
|
-1.41
+11.88%
|
-1.60
+33.33%
|
-2.40
+8.05%
|
-2.61
|
| Basic EPS |
|
-1.41
+11.88%
|
-1.60
+33.33%
|
-2.40
+8.05%
|
-2.61
|
| Basic Average Shares |
|
73.99
+9.03%
|
67.87
+38.46%
|
49.01
+12.34%
|
43.63
|
| Diluted Average Shares |
|
73.99
+9.03%
|
67.87
+38.46%
|
49.01
+12.34%
|
43.63
|
| Diluted NI Availto Com Stockholders |
|
-104.08
+4.33%
|
-108.79
+7.41%
|
-117.50
-3.22%
|
-113.84
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
404.21
-19.35%
|
501.20
+32.28%
|
378.88
-19.89%
|
472.94
|
| Current Assets |
|
282.51
+3.36%
|
273.34
+8.01%
|
253.07
-29.84%
|
360.69
|
| Cash Cash Equivalents And Short Term Investments |
|
276.28
+3.34%
|
267.35
+7.72%
|
248.19
-29.52%
|
352.14
|
| Cash And Cash Equivalents |
|
39.63
+42.19%
|
27.87
-10.20%
|
31.04
-17.21%
|
37.49
|
| Other Short Term Investments |
|
236.65
-1.18%
|
239.48
+10.28%
|
217.15
-30.99%
|
314.65
|
| Prepaid Assets |
|
3.82
+17.54%
|
3.25
-0.43%
|
3.26
-41.90%
|
5.62
|
| Other Current Assets |
|
2.41
-11.74%
|
2.73
+68.93%
|
1.62
-44.73%
|
2.93
|
| Total Non Current Assets |
|
121.70
-46.59%
|
227.87
+81.11%
|
125.81
+12.08%
|
112.25
|
| Net PPE |
|
101.15
-8.60%
|
110.67
-7.21%
|
119.28
+10.79%
|
107.66
|
| Gross PPE |
|
130.10
-1.08%
|
131.52
+0.42%
|
130.97
+15.41%
|
113.48
|
| Accumulated Depreciation |
|
-28.95
-38.89%
|
-20.84
-78.27%
|
-11.69
-100.77%
|
-5.82
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
1.04
-9.48%
|
1.15
+0.09%
|
1.15
+48.26%
|
0.78
|
| Construction In Progress |
|
10.57
-2.34%
|
10.82
+20.85%
|
8.95
-81.97%
|
49.66
|
| Other Properties |
|
52.01
-1.74%
|
52.93
-2.43%
|
54.25
-7.51%
|
58.65
|
| Leases |
|
66.49
-0.20%
|
66.62
+0.00%
|
66.62
+1413.36%
|
4.40
|
| Investments And Advances |
|
16.11
-85.41%
|
110.39
|
0.00
|
—
|
| Other Non Current Assets |
|
4.44
-34.72%
|
6.80
+4.01%
|
6.54
+42.37%
|
4.59
|
| Total Liabilities Net Minority Interest |
|
91.88
-1.44%
|
93.23
-11.72%
|
105.60
+4.83%
|
100.73
|
| Current Liabilities |
|
22.27
+17.70%
|
18.92
-18.92%
|
23.33
+5.82%
|
22.05
|
| Payables And Accrued Expenses |
|
9.31
+88.16%
|
4.95
-53.04%
|
10.54
-5.11%
|
11.11
|
| Payables |
|
2.09
+227.43%
|
0.64
-82.59%
|
3.67
+108.12%
|
1.76
|
| Accounts Payable |
|
2.09
+227.43%
|
0.64
-82.59%
|
3.67
+108.12%
|
1.76
|
| Current Accrued Expenses |
|
7.22
+67.55%
|
4.31
-37.29%
|
6.87
-26.44%
|
9.35
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
6.07
-23.40%
|
7.92
+17.79%
|
6.72
+0.46%
|
6.69
|
| Current Debt And Capital Lease Obligation |
|
6.89
+13.87%
|
6.05
-0.31%
|
6.07
+42.83%
|
4.25
|
| Current Capital Lease Obligation |
|
6.89
+13.87%
|
6.05
-0.31%
|
6.07
+42.83%
|
4.25
|
| Total Non Current Liabilities Net Minority Interest |
|
69.62
-6.31%
|
74.31
-9.68%
|
82.27
+4.56%
|
78.69
|
| Long Term Debt And Capital Lease Obligation |
|
69.53
-6.32%
|
74.22
-9.78%
|
82.27
+4.56%
|
78.69
|
| Long Term Capital Lease Obligation |
|
69.53
-6.32%
|
74.22
-9.78%
|
82.27
+4.56%
|
78.69
|
| Other Non Current Liabilities |
|
0.09
+0.00%
|
0.09
|
—
|
—
|
| Stockholders Equity |
|
312.32
-23.45%
|
407.98
+49.29%
|
273.29
-26.58%
|
372.21
|
| Common Stock Equity |
|
312.32
-23.45%
|
407.97
+49.28%
|
273.29
-26.58%
|
372.21
|
| Capital Stock |
|
0.01
+0.00%
|
0.01
+40.00%
|
0.01
+0.00%
|
0.01
|
| Common Stock |
|
0.00
|
0.00
-100.00%
|
0.01
+0.00%
|
0.01
|
| Preferred Stock |
|
0.01
+0.00%
|
0.01
|
0.00
|
0.00
|
| Share Issued |
|
71.08
+0.61%
|
70.65
+43.64%
|
49.18
+0.62%
|
48.88
|
| Ordinary Shares Number |
|
71.08
+0.61%
|
70.65
+43.64%
|
49.18
+0.62%
|
48.88
|
| Additional Paid In Capital |
|
960.22
+0.91%
|
951.52
+34.26%
|
708.71
+2.59%
|
690.81
|
| Retained Earnings |
|
-648.31
-19.13%
|
-544.22
-24.98%
|
-435.43
-36.96%
|
-317.93
|
| Gains Losses Not Affecting Retained Earnings |
|
0.41
-39.61%
|
0.67
+8325.00%
|
0.01
+101.18%
|
-0.68
|
| Other Equity Adjustments |
|
0.41
-39.61%
|
0.67
+8325.00%
|
0.01
+101.18%
|
-0.68
|
| Total Equity Gross Minority Interest |
|
312.32
-23.45%
|
407.98
+49.29%
|
273.29
-26.58%
|
372.21
|
| Total Capitalization |
|
312.32
-23.45%
|
407.98
+49.29%
|
273.29
-26.58%
|
372.21
|
| Working Capital |
|
260.25
+2.29%
|
254.42
+10.74%
|
229.74
-32.16%
|
338.64
|
| Invested Capital |
|
312.32
-23.45%
|
407.97
+49.28%
|
273.29
-26.58%
|
372.21
|
| Total Debt |
|
76.42
-4.80%
|
80.27
-9.13%
|
88.34
+6.52%
|
82.93
|
| Capital Lease Obligations |
|
76.42
-4.80%
|
80.27
-9.13%
|
88.34
+6.52%
|
82.93
|
| Net Tangible Assets |
|
312.32
-23.45%
|
407.98
+49.29%
|
273.29
-26.58%
|
372.21
|
| Tangible Book Value |
|
312.32
-23.45%
|
407.97
+49.28%
|
273.29
-26.58%
|
372.21
|
| Available For Sale Securities |
|
16.11
-85.41%
|
110.39
|
—
|
—
|
| Investmentin Financial Assets |
|
16.11
-85.41%
|
110.39
|
0.00
|
—
|
| Preferred Stock Equity |
|
0.01
+0.00%
|
0.01
|
—
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-88.70
+11.03%
|
-99.70
-15.71%
|
-86.16
-51.16%
|
-57.00
|
| Cash Flow From Continuing Operating Activities |
|
-88.70
+11.03%
|
-99.70
-15.71%
|
-86.16
-51.16%
|
-57.00
|
| Net Income From Continuing Operations |
|
-104.08
+4.33%
|
-108.79
+7.41%
|
-117.50
-3.22%
|
-113.84
|
| Depreciation Amortization Depletion |
|
9.19
+0.45%
|
9.15
+55.94%
|
5.87
+122.56%
|
2.64
|
| Depreciation And Amortization |
|
9.19
+0.45%
|
9.15
+55.94%
|
5.87
+122.56%
|
2.64
|
| Other Non Cash Items |
|
1.95
-14.65%
|
2.29
+2.88%
|
2.22
-43.53%
|
3.94
|
| Stock Based Compensation |
|
8.56
-48.84%
|
16.73
-2.72%
|
17.20
+2.03%
|
16.86
|
| Asset Impairment Charge |
|
0.79
|
0.00
-100.00%
|
4.10
|
0.00
|
| Operating Gains Losses |
|
-0.09
|
—
|
-0.03
-106.94%
|
0.49
|
| Gain Loss On Investment Securities |
|
-0.09
|
—
|
-0.03
-106.94%
|
0.49
|
| Change In Working Capital |
|
-0.43
+96.42%
|
-12.16
-211.33%
|
10.93
-67.62%
|
33.74
|
| Change In Prepaid Assets |
|
2.11
+254.80%
|
-1.36
-179.55%
|
1.72
+215.25%
|
-1.49
|
| Change In Payables And Accrued Expense |
|
2.46
+155.11%
|
-4.47
-205.83%
|
4.22
+53.17%
|
2.76
|
| Change In Payable |
|
2.46
+155.11%
|
-4.47
-205.83%
|
4.22
+53.17%
|
2.76
|
| Change In Account Payable |
|
2.46
+155.11%
|
-4.47
-205.83%
|
4.22
+53.17%
|
2.76
|
| Change In Other Current Liabilities |
|
-5.01
+20.82%
|
-6.33
-226.94%
|
4.99
-84.64%
|
32.47
|
| Investing Cash Flow |
|
100.32
+177.43%
|
-129.56
-263.96%
|
79.02
+142.78%
|
-184.69
|
| Cash Flow From Continuing Investing Activities |
|
100.32
+177.43%
|
-129.56
-263.96%
|
79.02
+142.78%
|
-184.69
|
| Net PPE Purchase And Sale |
|
-1.21
+72.60%
|
-4.41
+84.34%
|
-28.15
+40.25%
|
-47.11
|
| Purchase Of PPE |
|
-1.21
+72.60%
|
-4.41
+84.34%
|
-28.15
+40.25%
|
-47.11
|
| Capital Expenditure |
|
-1.21
+72.60%
|
-4.41
+84.34%
|
-28.15
+40.25%
|
-47.11
|
| Net Investment Purchase And Sale |
|
101.53
+181.13%
|
-125.15
-216.78%
|
107.16
+177.89%
|
-137.58
|
| Purchase Of Investment |
|
-238.56
+41.29%
|
-406.38
-56.16%
|
-260.23
+32.56%
|
-385.89
|
| Sale Of Investment |
|
340.09
+20.93%
|
281.23
-23.45%
|
367.39
+47.96%
|
248.31
|
| Financing Cash Flow |
|
0.14
-99.94%
|
226.08
+32618.38%
|
0.69
-99.68%
|
219.01
|
| Cash Flow From Continuing Financing Activities |
|
0.14
-99.94%
|
226.08
+32618.38%
|
0.69
-99.68%
|
219.01
|
| Net Common Stock Issuance |
|
0.00
-100.00%
|
225.07
|
0.00
-100.00%
|
217.17
|
| Proceeds From Stock Option Exercised |
|
0.14
-86.05%
|
1.01
+46.31%
|
0.69
-62.49%
|
1.84
|
| Net Other Financing Charges |
|
—
|
—
|
—
|
—
|
| Changes In Cash |
|
11.76
+471.36%
|
-3.17
+50.93%
|
-6.45
+71.54%
|
-22.68
|
| Beginning Cash Position |
|
30.62
-9.37%
|
33.78
-16.04%
|
40.24
-36.04%
|
62.91
|
| End Cash Position |
|
42.38
+38.41%
|
30.62
-9.37%
|
33.78
-16.04%
|
40.24
|
| Free Cash Flow |
|
-89.91
+13.64%
|
-104.11
+8.93%
|
-114.31
-9.79%
|
-104.11
|
| Amortization Of Securities |
|
-4.58
+33.74%
|
-6.91
+22.68%
|
-8.94
-992.91%
|
-0.82
|
| Common Stock Issuance |
|
0.00
-100.00%
|
225.07
|
0.00
-100.00%
|
217.17
|
| Issuance Of Capital Stock |
|
0.00
-100.00%
|
225.07
|
0.00
-100.00%
|
217.17
|
| Net Preferred Stock Issuance |
|
—
|
—
|
—
|
—
|
| Preferred Stock Issuance |
|
—
|
—
|
—
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-03-26 View
- 10-K2026-03-25 View
- 8-K2026-03-25 View
- 42026-01-20 View
- 42026-01-20 View
- 42026-01-08 View
- 42026-01-08 View
- 42026-01-08 View
- 10-Q2025-11-10 View
- 8-K2025-11-10 View
- 10-Q2025-08-12 View
- 8-K2025-08-12 View
- 42025-06-25 View
- 42025-06-20 View
- 42025-06-09 View
- 42025-06-09 View
- 42025-06-09 View
- 42025-06-09 View
- 42025-06-09 View
- 42025-06-09 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|